Duško Lainšček
Duško Lainšček is a researcher at the Chemical Institute who contributed to the development of the gene therapy for CTNNB1 syndrome. His work involved collaborative efforts across multiple research institutions, focusing on the safe delivery of gene therapy and the scientific validation of its therapeutic effects.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Slovenia:
Duško Lainšček explained that the development of gene therapy involved teamwork from many research institutions.
7